Aduromed Industries files patent application for containerized medical waste treatment system

Aduromed Industries, Inc. has announced that it successfully filed a U.S. patent on November 24, 2008 to protect the Company's proprietary technology for its new standard, containerized MedClean Systems that provide a turnkey solution for onsite regulated medical waste sterilization and volume reduction.

The patent application, entitled "Containerized Medical Waste Treatment System and Related Method," focuses on the design and configuration of Aduromed's new standard, containerized MedClean Systems.

"The Aduromed team has invested significant time and effort into evolving its operating model to meet the business and regulatory demands of the health care institutions it targets," commented Scott Grisanti, President and Chief Executive Officer of Aduromed. "The resultant solutions have the potential to produce a sustainable competitive advantage, and we have taken significant steps to protect this intellectual property through this patent filing. The patent pre-stages market introduction of the MedClean series of containerized systems that are designed to make it easier for health care institutions to implement onsite processing solutions for regulated medical waste that reduce costs, mitigate risk, and enhance Green profiles."

The patent application also covers the specific protocol employed to accomplish sterilization in the company's autoclave subsystem. The protocol implements a sequence of differential heating and vacuum cycles designed to optimize efficacy and balance cycle time.

"The treatment protocol included in the patent is the result of research conducted with customers and industry experts that has yielded the most extensive body of work in the industry," added Mr. Grisanti. "This tested and validated protocol is a key component of our proprietary software and hardware platform, enabling MedClean solutions to meet and exceed the most demanding efficacy standards throughout all 50 states while providing the throughput required to economically address the highest volume generators of regulated medical waste. Our third-party validated efficacy results, combined with first in industry MedClean container configurations, are expected to accelerate adoption of Aduromed's solutions."